Physician profile
Ajay Joseph
NPI 1104180553
$7,887.55
in general payments reported to CMS, 2019-2025
44 companies · $610 in 2025
The $610 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,589 · 2020: $858 · 2021: $1,308 · 2022: $1,317 · 2023: $492 · 2024: $715 · 2025: $610.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,816.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,743.46 | 2019-2025 | General - Balloon Catheters, General - Stents |
| Novartis Pharmaceuticals Corporation | $694.85 | 2019-2025 | |
| Amgen INC. | $537.65 | 2019-2024 | Repatha |
| Abiomed | $444.67 | 2024-2025 | Impella |
| Cook Medical LLC | $353.18 | 2019 | |
| Janssen Pharmaceuticals, INC | $342.45 | 2019-2023 | Xarelto |
| Abbott Laboratories | $280.88 | 2019-2025 | Esprit, Cardiomems |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $236.93 | 2019-2023 | Lifevest |
| Pfizer INC. | $230.43 | 2019-2022 | |
| Amarin Pharma, INC. | $220.11 | 2019-2022 | |
| Stryker Corporation | $216.95 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Astrazeneca Pharmaceuticals LP | $185.77 | 2019-2024 | Andexxa |
| Biotronik INC. | $181.43 | 2021 | |
| Novo Nordisk INC | $178.11 | 2022-2023 | Rybelsus, Ozempic |
| Inari Medical, INC. | $172.95 | 2020-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Joseph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.